This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Illumina Cambridge Limited. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Michael Chesney: Innovator in Nucleic Acid Library Preparation
Introduction
Michael Chesney is a notable inventor based in Nr Saffron Walden, GB. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid library preparations. His work focuses on improving the accuracy of sample identification in multiplex next-generation sequencing.
Latest Patents
Chesney holds a patent for "Compositions and methods for improving sample identification in indexed nucleic acid libraries." This invention addresses the challenges of correct sample identification in indexed nucleic acid library preparations. The method involves exonuclease treatment and the optional blocking of the 3' ends of pooled indexed polynucleotides from multiple samples prior to amplification and sequencing. He has 1 patent to his name.
Career Highlights
Michael Chesney is currently employed at Illumina Cambridge Limited, a leading company in the field of genomics. His role at Illumina allows him to work on cutting-edge technologies that advance the capabilities of genetic sequencing.
Collaborations
Chesney has collaborated with notable colleagues, including Vincent Peter Smith and Claire Bevis-Mott. These partnerships have contributed to the development of innovative solutions in the field of nucleic acid research.
Conclusion
Michael Chesney's contributions to the field of molecular biology and his innovative patent demonstrate his commitment to advancing genetic research. His work continues to impact the accuracy and efficiency of nucleic acid library preparations.